Osborn Williams & Donohoe LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,131 filers reported holding NOVARTIS A G in Q1 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.4%.

Quarter-by-quarter ownership
Osborn Williams & Donohoe LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q1 2020$4,682,000
-16.7%
56,780
-4.4%
0.62%
+9.4%
Q4 2019$5,621,000
+5.1%
59,366
-3.6%
0.56%
+4.3%
Q3 2019$5,350,000
-3.0%
61,566
+1.9%
0.54%
-5.3%
Q2 2019$5,517,000
+7.7%
60,416
-3.4%
0.57%
+8.0%
Q1 2019$5,123,000
+35.9%
62,574
+42.5%
0.53%
-20.8%
Q4 2018$3,769,000
-12.9%
43,915
-12.6%
0.66%
-1.2%
Q3 2018$4,328,000
+12.5%
50,238
-1.3%
0.67%
+3.4%
Q2 2018$3,846,000
-6.8%
50,913
-0.2%
0.65%
-8.8%
Q1 2018$4,126,000
-3.7%
51,038
+0.0%
0.71%
-2.7%
Q4 2017$4,284,000
-7.0%
51,023
-4.9%
0.73%
-11.6%
Q3 2017$4,606,000
+0.9%
53,645
-2.0%
0.83%
+0.4%
Q2 2017$4,567,000
+3.0%
54,715
-8.3%
0.83%
+3.4%
Q1 2017$4,432,000
-1.0%
59,681
-2.9%
0.80%
-4.9%
Q4 2016$4,479,000
-11.3%
61,488
-3.9%
0.84%
-12.9%
Q3 2016$5,051,000
-8.3%
63,970
-4.2%
0.97%
-9.7%
Q2 2016$5,511,000
+11.9%
66,794
-1.7%
1.07%
+8.5%
Q1 2016$4,923,000
-20.6%
67,953
-5.6%
0.99%
-22.9%
Q4 2015$6,197,000
-3.5%
72,022
+2.4%
1.28%
-8.2%
Q3 2015$6,425,000
-10.3%
70,3670.0%1.39%
-3.2%
Q2 2015$7,163,000
+0.1%
70,367
-3.0%
1.44%
+3.5%
Q1 2015$7,156,000
+5.5%
72,564
-0.9%
1.39%
+4.5%
Q4 2014$6,785,000
-0.7%
73,224
+0.9%
1.33%
-6.5%
Q3 2014$6,830,000
+4.7%
72,564
-0.4%
1.42%
+5.5%
Q2 2014$6,522,000
+5.2%
72,856
-0.1%
1.35%
-1.2%
Q1 2014$6,201,000
+5.4%
72,941
-0.3%
1.36%
+3.5%
Q4 2013$5,881,000
+3.9%
73,160
-0.9%
1.32%
-4.6%
Q3 2013$5,662,000
+9.0%
73,810
+0.5%
1.38%
+2.0%
Q2 2013$5,194,00073,4551.36%
Other shareholders
NOVARTIS A G shareholders Q1 2019
NameSharesValueWeighting ↓
MANAGED ASSET PORTFOLIOS, LLC 332,962$27,452,0007.32%
Mawer Investment Management Ltd. 7,721,327$636,623,0005.86%
Martin Investment Management, LLC 133,246$10,986,0005.56%
SCHARF INVESTMENTS, LLC 1,330,175$109,673,0005.48%
Hansberger Growth Investors, LP 46,663$3,847,0005.19%
Bain Capital Public Equity Management II, LLC 440,233$36,297,0004.25%
First Fiduciary Investment Counsel, Inc. 187,633$15,470,0004.10%
GARLAND CAPITAL MANAGEMENT INC 53,555$4,416,0004.02%
Lowell Blake & Associates Inc. 37,219$3,069,0003.94%
PRENTISS SMITH & CO INC 68,027$5,609,0003.89%
View complete list of NOVARTIS A G shareholders